bmi requirements for semaglutide GLP-1 Treatment Specialist Allocation of Semaglutide According to

But this has led to Ozempic shortages, directly affecting people with Type 2 diabetes who rely on the drug

This happens because the medication, originally intended to create a depot in loose fatty tissue, instead sits in denser muscle fibers that do not disperse it as easily

The variability introduced by factors like the type of ischemia, diabetes, hypertension, heart failure, and aging necessitates patient stratification and the development of personalized therapeutic strategies

A realistic goal depends on your starting weight, health conditions, medication options, and consistency

According to the FDA, Wegovy is indicated for chronic weight management in patients with a body mass index (BMI) of 27 kg/m2 or greater who have at least one weight-related ailment or in patients with a BMI of 30 kg/m2 or greater

Dhivagaran T, Butt F, Arunasalam L, et al